Dopaminergic neurons of the substantia nigra provide one of the major neuromodulatory Inputs to the neostriatum. Recent in situ hybridization experiments have suggested that postsynaptic dopamine receptors are segregated in striatonigral and striatopallidal neurons. We have tested this hypothesis in acutely isolated, retrogradely labeled striatonigral neurons by examining the neuromodulatory effects of selective dopaminergic agonists on Na currents and by probing single-cell antisense RNA populations with dop receptor cDNAs. In most of the neurons examined (20/31), the application of the Di dopamine receptor agonist SKF 38393 reduced evoked whole-cell Na+ current. The D2 agonists quinpirole and bromocriptine had mixed effects; in most neurons (23/42), whole-cell Na+ currents were reduced, but in others (8/42), currents were increased. In cell-attached patch recordings, bath application of SKF 38393 decreased currents as in wholecell recordings, whereas quinpirole consistently (6/10) enhanced currents-suggesting that D2-like receptors could act through membrane delimited and non-delimited pathways. Changes in evoked current were produced by modulation of peak conductance and modest shifts in the voltage dependence of steady-state inactivation. Antisense RNA probes of dopamine receptor cDNA Southern blots consistently (5/5) revealed the presence of Di, D2, and D3 receptor mRNA in single striatonigral neurons. These rnmdings argue that, contrary to a strict receptor segregation hypothesis, many striatonigral neurons colocalize functional Di, D2, and D3 receptors.
The role of the dopaminergic nigrostriatal system in controlling the excitability of neostriatal neurons has been intensely studied since it became clear that the loss of this innervation was responsible for the psychomotor symptoms ofParkinson disease (1) . Molecular cloning and hybridization studies (2, 3) have revealed that the postsynaptic actions of dopamine are mediated by a family of five G-protein-coupled receptors (D1-D5). In situ hybridization experiments of Gerfen et al. (4, 5) have suggested that two members of this family-the D1 and D2 receptors-are segregated in the two major efferent populations of the neostriatum that project to the substantia nigra and pallidum. They have inferred from their findings that these pathways can be selectively modulated by D1 and D2 agonists. In its strictest form, this hypothesis requires that striatonigral neurons express only those dopamine receptors with a D1 pharmacological profile (D1 and D5) and that striatopallidal neurons express only those receptors with a D2 profile (D2, D3, and D4).
This model of receptor segregation is difficult to reconcile with much of the biochemical and physiological literature addressing the effects of dopamine in the neostriatum (6) (7) (8) (9) (10) (11) (12) . Gerfen et al.' s hypothesis implicitly argues that the appearance of convergence is a consequence of the failure to separate direct postsynaptic effects from indirect effects mediated by adjacent neurons. Such a separation is virtually impossible in any preparation that preserves local tissue architecture or fails to isolate individual neurons. Therefore, to provide a clear test of this hypothesis, we have studied acutely isolated striatonigral neurons identified by retrograde labeling. Two approaches were used to determine the extent of receptor colocalization. First, by using whole-cell and cell-attached voltage clamp, the modulatory effects of selective D1 and D2 dopaminergic agonists on Na+ currents were studied. Second, to provide a molecular characterization of the receptors mediating the physiological response, the RNA from individual striatonigral neurons was amplified and used to detect dopamine receptor cDNAs.
MATERIALS AND METHODS
Retrograde Labeling and Cell Isolation. Injections of fluorescent rhodamine-impregnated microbeads (13) into the substantia nigra were made 2-12 days prior to the experiment. Animals were anesthetized with a mixture of ketamine (100 mg/kg) and xylazine (100 mg/kg) i.p. A suspension of microbeads in saline (Lumafluor, New York) was injected via a stereotaxically placed microsyringe needle. Three injections (3 ,ul each) were made on each side, separated by 0.5 mm in the rostrocaudal direction. Bead injections into the substantia nigra typically labeled about half the cells in frontal sections ofthe striatum (Fig. 1A) , as well as about half of the cells acutely dissociated from this region ( Fig. 1 B and C). Neurons were acutely isolated as described (14) .
Patch-Clamp Recordings. Voltage-clamp recordings were made at room temperature (20-220C) with conventional techniques (15, 16) RNA Amplification. Striatal neurons were dissociated, identified, and recorded from as above except that the patch-clamp electrode was backfilled with a solution containing dNTPs, oligo(dT) primer, and reverse transcriptase (17, 18) ; positive pressure was maintained on the electrode during the approach to avoid entry of cellular debris. After seal rupture, the electrode and attached cell were lifted into a stream of control salt solution and the mRNA was sucked into the pipette. First-strand cDNA synthesis and amplification proceeded as described (17, 18) . The antisense RNA (aRNA) probe was made by incorporating radiolabeled nucleotides into the second round of aRNA amplification, as described (18) . Each of the cDNAs (2 ug) was digested with BamHI (except for the glycine receptor cDNA, which was digested with HindIII), electrophoresed through a 1% agarose gel, and transferred to nitrocellulose. cDNAs were visualized prior to transfer by staining with ethidium bromide. After prehybridization in 6x standard saline citrate (SSC)/5x Denhardt's solution/60% (vol/vol) formamide with salmon sperm DNA (25 ,ug/ml) at 3rC overnight, probe hybridization was carried out at 37°C in the same solution. The blots were washed successively in 5x SSC/1% SDS at 370C for 1 hr, 2x SSC/1% SDS at 50°C for 1 hr, and O.lx SSC/1% SDS at 50°C for 1 hr. Blots were air-dried and apposed to x-ray film for 72 hr at -70°C with an intensifying screen. For PCR amplification, templates were obtained from reverse transcription of aRNAs that were amplified from single striatonigral neurons (18) . Primers used for D1 receptor RNA detection were 5'-CGCGGATCCACAAGCTTCTA-CAGGATTGCCCAGAAGCAA-3' (nucleotides 1051-1089) and 5'-CGCGGATCCGAAGCTTTCACTTTAGAACTT-TCGTCTCCCT-3' (nucleotides 1213-1252). The size of the amplified DI cDNA is 203 base pairs (bp). Primers used for %2 receptor RNA detection were 5'-GAGGCAACCTGAAT-TCACCACTCAAGGATGCTGCC-3' (nucleotides 823-859) and 5'-TGGTCTGCAGCTAAAAGAACTTGGCAAT CCTGGG-3' (nucleotides . The size of the amplified D2 cDNA is 170 bp; the primers used for D3 receptor RNA detection were 5'-TGTAATACGACTCACTATAG-3' and 5'-ATGCATCCAACGCGTTGGGA-3'. The size of the amplified D3 cDNA is 420 bp. The PCR mixture contained 1/30th of the cDNA template made from a single cell, 50 ng of each primer, 1 unit of Taq DNA polymerase, 0.25 mM dNTPs, lx PCR buffer (Cetus/Perkin-Elmer), and 2 mM MgCI2. Temperature cycling was performed (950C for 1 min, 530C for 1 min, 720C for 1 min) for a total of 35 cycles. After phenol/chloroform extraction and ethanol precipitation, onethird of the total PCR products was analyzed by electrophoresis in a 1.5% agarose gel. For cDNA visualization the gel was stained with ethidium bromide. Photomicrographs of the gels and blots were scanned and digitally processed with software supplied by the National Institutes ofHealth (IMAGE version 1.41).
RESULTS
The ionic currents seen under our recording conditions exhibited biophysical and pharmacological properties similar to those of Na+ currents described in other brain neurons (19) (20) (21) (22) . These currents play an important role in subthreshold integration and spike generation in the neostriatum (23, 24) . As described for monoamines in other tissues (25, 26) , the application of dopamine (10- (1-5 ,uM) reduced the amplitude of the evoked Na+ current (Fig. 2A) . The modulation by SKF 38393 appeared to be mediated by DI receptors, as it was blocked by the specific DI agonist SCH 23390 (1 ,uM) ( Fig. 2A ; n = 4) and unaffected by the 12 receptor antagonist (-)-sulpiride (5 AM) (n = 6). Bath application of 8-bromo-cAMP (1 mM) partially mimicked this effect (n = 2), suggesting that the modulation was mediated by D1 receptors that were positively coupled to adenylate cyclase.
In 55% (23/42) of the neurons tested in whole-cell recordings, the application of D2 agonist, quinpirole (n = 31) or bromocriptine (n = 11), produced a time-locked decrease in evoked current amplitude (Fig. 2B) . The decrease was not a consequence of the enhancement of an outward current, as the application of the specific Na+ channel blocker tetrodotoxin eliminated the evoked current and the change produced by quinpirole (n = 5). The response to quinpirole (100 nM) was blocked by the D2 receptor antagonist (-)-sulpiride (1 pM) (Fig. 2B , n = 5), suggesting that the modulation was mediated by D2-like receptors.
In about 20% (8/42) of our whole-cell recordings, the application of D2 agonists increased the amplitude of the current evoked from -70 mV. (-)-Sulpiride antagonized this response, suggesting that it also was mediated by a D2-like receptor (n = 4). Similar responses to D2 agonists were observed in more than half (6/10) of cell-attached patch recordings with bath-applied agonists (Fig. 2C) . D2 agonists never decreased the evoked current in cell-attached patches. The Di agonist SKF 38393, on the other hand, decreased the evoked current in most patches (4/5), as in whole-cell reNeurobiology.: Surmeier et al. Fig. 3A ; in 10 cells, peak current was reduced an average of 22% and the half-inactivation voltage shifted an average of -5.6 mV. This modulation is similar to that produced by cAMP-dependent kinase phosphorylation of Na+ channels (27) . When D2 agonists in- 
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Quinpirole (100 nM) produced a similar reduction that was antagonized by the D2 receptor antagonist (-)-sulpiride (1 ,uM). After recovery, the specific D1 agonist SKF 38393 (1 hM) was applied. (C) In cell-attached patch recordings, the D2 agonist quinpirole (1 ,AM) enhanced Na+ currents evoked by a step to -20 mV from a holding potential of -80 mV.
cordings. In the cell-attached recording configuration, bathapplied agonists do not interact with the membrane containing the channels being modulated. As a consequence, the modulatory responses seen in this configuration must be dependent upon soluble second messengers produced by activation of receptors outside of the recorded patch. These experiments suggest that DI-and D2-like receptors can reciprocally modulate Na+ currents through a soluble second messenger (presumably cAMP) in many striatonigral neurons. These results also suggest that the reduction in Na+ current produced by D2 agonists is mediated by a membranedelimited pathway, as it was not seen in cell-attached patches.
An examination of the biophysical mechanisms underlying the changes in evoked current revealed three patterns of creased Na+ current, the biophysical changes were complementary to those of DI agonists. In the example of Fig. 3B , bromocriptine (500 nM) shifted inactivation-voltage dependence toward more depolarized values and increased the maximal current. In 4 cells, the half-inactivation voltage shifted an average of 3.2 mV and the peak current increased an average of l9o. In contrast, the membrane delimited modulation produced by D2 agonists did not change peak current but did shift steady-state inactivation toward more negative potentials (Fig. 3C) . In 8 neurons where quinpirole (100-500 nM) reduced current amplitudes, the mean halfinactivation voltage shifted an average of -5.1 mV. The maximal current in these cells was not altered significantly nor was the voltage dependence of activation. The modulation produced by quinpirole was not seen in neurons cultured from the embryonic striatum (n = 8; data not shown), suggesting that its mechanism of action differed from that reported for neuroleptics (28) .
These findings are not only contrary to a strict segregation of dopamine receptors but suggest that many striatonigral neurons coexpress two Drlike receptors, in addition to a D1-like receptor. However, at present, the pharmacological tools necessary to differentiate D2, D3, and D4 receptors are not available. As a consequence, we turned to a recently developed technique for amplifying the mRNA of single cells to characterize the receptors (17, 18) . Fig. 4A Upper shows an ethidium bromide-stained gel containing cDNAs that were transferred to nitrocellulose for probing with radiolabeled aRNA from a single striatonigral neuron. The dopamine receptor cDNAs were constructed from the mRNA sequences coding for nonhomologous regions of the third cytoplasmic domain of the receptors. Fig. 4A Lower shows the autoradiogram resulting from aRNA hybridization to the Southern blot. Positive hybridization to cDNAs for DI, D2, and D3 dopamine receptors, the (1 subunit of the type A y-aminobutyrate receptor, and the Na+ channel is apparent; longer development times also revealed hybridization to the neurofilament cDNA. All five of the striatonigral neurons subjected to aRNA amplification had detectable levels of D1, D2, and D3 receptor mRNAs. These receptor signals did not result from amplification of genomic DNA, since aRNA populations did not hybridize to known middle-repetitive sequences, and hybridization intensity was not uniform. Two other experiments have shown that retrogradely labeled cells possess mRNA for substance P but not enkephalin, in agreement with their identification as striatonigral neurons (29) (30) (31) .
To further test the specificity of the dopamine receptor hybridization, regions of aRNA molecules coding for the third cytoplasmic domain of each receptor were amplified with the PCR and subjected to size analysis. This was accomplished by converting the aRNA into cDNA [by using random primers to prime reverse transcription (18) ] and then performing PCR using oligonucleotide primers that were specific for regions of the third cytoplasmic loop of the distinct receptor subtypes. For DI receptor aRNA, this should yield a cDNA of 203 bp; D2 and D3 receptor aRNAs should yield cDNAs of 170 and 420 bp, respectively. Fig. 4B shows the ethidium bromide-stained gel of PCR-amplified cDNA made from the aRNA of two striatonigral neurons. In cell 1, cDNA of the predicted sizes for DI, D2, and D3 receptor mRNA was evident. In cell 2, cDNA of the predicted sizes was seen plainly for DI and D3 receptors whereas that for the D2 receptor was faint. As the D2 PCR cDNA was from a region of the D2 mRNA transcript that is normally spliced, the absence of an unspliced product in either cell provides further evidence that genomic DNA was not amplified. These experiments establish the specificity of the aRNA hybridization and the supposition that (6) . On the other hand, Greengard's group (7) has shown that in isolated neostriatal neurons, DI and D2 agonists can act synergistically to suppress Na+/K+ ATPase activity. Physiological studies using dopamine have revealed complex response patterns of excitation and inhibition of evoked activity (8, 34) that were attributed to indirect effects or coactivation of Di and D2 receptors. However, the use of receptor-selective agonists has clarified the picture only for the DI receptor-mediated modulation, for which a reduction in evoked discharge has consistently been reported (9) (10) (11) 35) . Calabresi et al. (35) attributed this effect to a reduction of Na+ current, as we have confirmed. D2 agonists, on the other hand, have been reported to either enhance evoked discharge (10) or reduce activity (12) . The cooperative reduction in activity by DI and D2 agonists is most commonly observed in the ventral striatum/nucleus accumbens (36) , where the apparent density of 13 receptors is highest (3) . This distribution can readily be reconciled with our results if one assumes that the membrane-elimited reduction in Na+ current produced by D2 agonists was mediated by D3 receptors and the non-membrane-delimited enhancement was mediated by D2 receptors. It remains to be established how these receptors are distributed over the somatodendritic membrane and how their activation by dopaminergic afferent fibers shapes the integrative properties of neostriatal neurons.
